New analysis of patients requiring dialysis or kidney transplant shows men are far more likely than women to get kidney failure
Our kidneys filter out toxic waste from the blood and regulate the fluid balance in the body as well as the balance of electrolytes and acid/base amongst others. Kidneys are important organs whose functions most of us take for granted, but when kidneys silently stop working this can create a life threatening situation.
Renal replacement therapy, RRT, (dialysis or kidney transplantation) may save the lives of many patients for years and even decades, as kidney function can be replaced by machines for a long period of time – but patients on dialysis (and transplanted patients to a lesser extent) have shorter life expectancies. This is why kidney failure (end-stage renal disease) should be prevented wherever possible.
The analysis also showed that the incidence of men starting renal replacement therapy due to diabetes and to glomerulonephritis/sclerosis was more than double that of their female counterparts.
A new analysis of data in the ERA-EDTA Registry shows that men are affected by kidney failure much more often than women. In 2016, 26,446 men and 14,820 women started renal replacement therapy. Amongst older patients (>75 years of age), the difference was even more striking: the incidence in men was 2.7 times higher than that in women. ‘One can only speculate about the reasons’, explains Professor Ziad Massy (Paris), Clinical Nephrology Governance Chair/Chair of the Registry. The protective effects of oestrogens in women and/or the damaging effects of testosterone might cause kidney function to decline faster in men than in women. Moreover, elderly women seem to be more inclined to choose conservative care instead of RRT.
However, hypertension or diabetes may also be implicated. There are distinct gender differences in the incidence and severity of hypertension. It is more common in men and could be prevented by lifestyle changes. ‘You can reduce it to a simple formula’, says Massy. `Beyond treatment, more sports and less body weight will result in lower blood pressure. ´
The analysis also showed that the incidence of men starting renal replacement therapy due to diabetes and to glomerulonephritis/sclerosis was more than double that of their female counterparts. Again therapeutic strategies as well as lifestyle changes are available to optimize the control of diabetes.
Finally, women are known to have better outcomes for some forms of glomerulonephritis, e.g. membranous (MGN) as well as focal and segmental glomerulosclerosis (FSGS), which might explain why fewer women have to start dialysis because of these diseases. Additionally, Professor Massy adds, `if we want to reduce the incidence of chronic kidney disease in men, we should therefore concentrate on the early detection and control of these risk factors. Obviously, we need to broadcast these messages if we want to reduce the number of men who have to start dialysis’.
